US States Enact E-Cigarette Bans, PMTA Registry Bills Trigger Controversy

Regulations by 2FIRSTS, edited by Sophia
May.06.2024
US States Enact E-Cigarette Bans, PMTA Registry Bills Trigger Controversy
Virginia bans flavored e-cigarettes, Iowa still undecided. Critics argue laws harm smoking cessation options. Major economic impact expected.

According to overseas media FilterMag, on May 2nd, it was reported that flavored e-cigarettes will be banned in the state of Virginia, but the ban will not take effect until one year later. Meanwhile, the decision on similar legislation in Iowa is pending the governor's signature or veto. These are just the latest PMTA registration laws, which are increasingly spreading across the United States under the guise of protecting consumers from unregulated products. Critics argue that these laws harmfully restrict people's options for quitting smoking.

 

Iowa Governor Kim Reynolds has not indicated whether she will sign a bill passed by the legislature in April. The Consumer Advocates for Smoke-free Alternatives Association (CASAA) has dubbed it the "Big Tobacco Protection Act." In Virginia, lawmakers also recently passed a registration bill, which Governor Glenn Youngkin (R) approved but with an amendment to delay implementation until July 1, 2025. The bill was passed by the legislature in April.

 

Oklahoma, Louisiana, and Alabama have implemented the PMTA registration legislation, according to Ecigator reports. While laws in Kentucky, Utah, and Wisconsin are set to take effect by 2025 (though there is ongoing litigation against the legislation in Kentucky), a report states that "legislators in about 20 other states are currently considering similar bills.)

 

According to advocates for harm reduction in tobacco, banning flavored e-cigarettes will only lead consumers to turn to the illegal market or even revert back to traditional cigarettes. Research also indicates that the choice of flavors is highly important for individuals transitioning from cigarettes to e-cigarettes.

 

However, tobacco companies that are actively promoting the above-mentioned legislation have a different perspective on this. They believe that these laws will help combat the illicit tobacco market and ensure that all kinds of businesses accept products authorized by the U.S. Food and Drug Administration (FDA).

 

Critics of these bills argue that small businesses and individuals trying to quit smoking will suffer. More than 1,800 people in Virginia could lose their jobs, and the state could lose over $250 million in economic benefits. Small businesses will also face fines of $1,000 per day for each unapproved product they sell. While tobacco giants are advocating for the ban, the public is skeptical of their motives.

 

Most legislators do not understand that the purpose of the PMTA registration is to ban the sale of the majority of e-cigarette products intended for use by adults in this state.

 

The FDA is facing harsh criticism from tobacco harm reduction advocates for denying millions of PMTA applications. They argue that the barriers to submission are so high that only the largest companies with significant financial and scientific resources have a chance at authorization.

 

However, one of the sponsors of the legislation, Virginia Delegate Rodney Willett (D-Henrico), said that despite the lengthy challenge, the FDA's program is important because a large number of e-cigarette products from China are flooding in, which he referred to as being "largely unregulated and untaxed in most cases." Willett believes, "Most legislators do not understand that the purpose of PMTA registration is to ban the sale of the vast majority of e-cigarette products used by adults in this state." "They think they are fighting against villains from China, but in reality, they are making the lives of their own constituents worse."

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

From Border-Logistics Insiders to Retail Service Stations, Australia Mounts a Sweeping Crackdown on the Illicit Nicotine Trade as iGET Vapes Surface in A$80 Million Crime Networks
From Border-Logistics Insiders to Retail Service Stations, Australia Mounts a Sweeping Crackdown on the Illicit Nicotine Trade as iGET Vapes Surface in A$80 Million Crime Networks
Australian authorities have disclosed two major enforcement actions that go beyond product seizures and retail closures to examine how illicit tobacco and vape networks operate. On Aug. 14, the Multi Agency Strike Team said seven people had been charged and two criminal networks were valued by authorities at a combined A$80 million, or about US$56.8 million. Investigators allege the groups used bonded warehouses, freight businesses and “trusted insiders” in legitimate industries to circumvent border controls. In a separate operation on Aug. 11, more than 100 service stations were targeted as authorities sought information on illicit tobacco importation, distribution networks and the movement of sales proceeds.
Aug.17
After Apple Business Decline, South Korea’s ITM Semiconductor Expands KT&G Vape Supply Chain as Vape Revenue Rises 24.8%
After Apple Business Decline, South Korea’s ITM Semiconductor Expands KT&G Vape Supply Chain as Vape Revenue Rises 24.8%
South Korean electronics component supplier ITM Semiconductor is reshaping its business portfolio after a decline in Apple-related protection circuit business, expanding its supply of vape devices and cartridges to KT&G. According to News1 on August 18, 2026, ITM’s vape-related revenue rose 24.8% year on year to 75.5 billion won in the first half of 2026. The company began mass production of vape devices at its Cikarang, Indonesia facility in January 2026, strengthening export manufacturing capacity. Meanwhile, Samsung-related protection circuit sales continued to grow, providing support during the transition.
Aug.20
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada's federal government is considering changes to current restrictions on where nicotine pouches can be sold, potentially allowing authorized products to return to convenience stores and other general retail channels, although no decision has been made. Since 2024, emerging nicotine replacement therapy products such as nicotine pouches have been largely restricted to behind-the-counter pharmacy sales. Health Canada, meanwhile, continues to recall unauthorized and higher-strength nicotine pouches, indicating that the current discussion concerns retail access for authorized products rather than a broad relaxation of nicotine pouch regulation.
Sep.14
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
Product | BAT Launches glo Hyper pro+ in Japan, Upgrading the Hyper Platform With Faster Start and Smart Device Management
Product | BAT Launches glo Hyper pro+ in Japan, Upgrading the Hyper Platform With Faster Start and Smart Device Management
British American Tobacco Japan (BAT Japan) has introduced glo Hyper pro+, an upgraded device within the existing glo Hyper platform. The device adds QuickStart™ rapid heating technology, an EasyView™ display and maintenance notification features to improve daily usability. Launched in Japan on July 13, 2026, glo Hyper pro+ maintains compatibility with existing Hyper-format tobacco sticks, including neo, Lucky Strike and KENT.
Jul.30
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22